Lopez-Rios et al. compared the Cobas BRAF Mutation Test with Sanger sequencing observing invalid results (DNA not amplified, difficult sequence interpretation, insufficient tumor content or DNA) in 8/116 specimens with Sanger vs. 0/232 with the Cobas BRAF test. This evidence concerns the gene BRAF and neoplasm.